drugs, or the development of new drugs or therapies to treat neurological or neuropsychiatric disorders. We especially seek applicants whose research would complement our existing strengths in neuropharmacology studying regulation of neuronal circuits, synaptic plasticity, neurotransmitter receptors, ion channels, cell adhesion molecules, signal transduction, glia and gene expression in control of neuronal function in learning and memory, neurodegeneration, addiction, ischemic brain injury, intellectual disability, schizophrenia, and autism.
The Department of Pharmacology is a collegial and collaborative interdisciplinary scientific group, with strengths in neuroscience, cancer research, structural biology, epigenetics, cellular optogenetics, glial biology, and bioinformatics. We encourage applications from all individuals who would thrive in a collaborative and collegial scientific environment. Applicants should also be enthusiastic about teaching and serving as research mentors in our interdepartmental graduate training programs such as the Pharmacology Graduate Program and the Neuroscience Graduate Program.
Applicants must have a PhD and/or MD degree and appropriate and sufficient post-doctoral experience to establish and/or maintain an independent research program competitively funded by extramural grant support. The department offers outstanding resources to support new faculty, including competitive salary and start-up support, junior faculty mentoring and guidance, well-supported core facilities and a strong collegial neuroscience research environment on campus.
To Apply:
Applicants should submit a single combined PDF that includes: (1) a cover letter, (2) curriculum vitae, (3) a 2-3 page statement of research interests and future directions, and (4) contact information for three references.
Applications can be sent by applying via CU Careers posting #40947.
Apply online: https://cu.taleo.net/careersection/2/jobdetail.ftl?job=40947&lang=en
Applications should be submitted by November 30, 2026.
